FDA Inspection 1187483 — DX PRODUCTS LIMITED

DX PRODUCTS LIMITED — FEI 3010386378

The FDA completed an inspection of DX PRODUCTS LIMITED on Nov 3, 2022 in Wakefield. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 4 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Nov 3, 2022
Fiscal Year
2023
Product Type
Devices
Project Area
Compliance: Devices
Location
Wakefield (United Kingdom)

Citations

IDCFRDescription
1471321 CFR 820.198(a)Lack of or inadequate complaint procedures
1472121 CFR 820.70(g)(2)Periodic equipment inspections
317021 CFR 820.198(b)Review and evaluation for investigation
47921 CFR 820.50Purchasing controls, Lack of or inadequate procedures

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.